Masahiro Yamashita Selected Research

Protein D-Aspartate-L-Isoaspartate Methyltransferase (Protein L Isoaspartate D Aspartate O Methyltransferase)

3/2018	Deficiency of protein-L-isoaspartate (D-aspartate) O-methyl-transferase expression under endoplasmic reticulum stress promotes epithelial mesenchymal transition in lung adenocarcinoma.
4/2016	Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Yamashita Research Topics

Disease

9	Infections 12/2021 - 11/2005
4	Idiopathic Pulmonary Fibrosis 01/2021 - 04/2013
3	Neoplasms (Cancer) 04/2016 - 06/2012
2	Peritoneal Fibrosis 01/2021 - 03/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 01/2018
2	Peritonitis 01/2020 - 11/2017
2	Adenocarcinoma of Lung 03/2018 - 04/2016
2	Asthma (Bronchial Asthma) 05/2016 - 09/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 01/2013
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Spasm (Spasms) 01/2022
1	Acute Lung Injury 01/2022
1	Lung Injury 01/2022
1	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2022
1	Autism Spectrum Disorder 04/2020
1	Schizophrenia (Dementia Praecox) 04/2020
1	Major Depressive Disorder (Major Depressive Disorders) 04/2020
1	Ischemia 01/2020
1	Obturator Hernia 01/2020
1	Wounds and Injuries (Trauma) 01/2019
1	Hemorrhage 01/2019
1	Hypoxia (Hypoxemia) 03/2018
1	Cryptogenic Organizing Pneumonia 01/2018
1	Inflammation (Inflammations) 11/2017
1	Fistula 11/2017
1	Pneumonia (Pneumonitis) 12/2016
1	Lung Neoplasms (Lung Cancer) 04/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Respiratory Hypersensitivity 09/2013
1	Airway Remodeling 09/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2013
1	Vasculitis (Vasculitides) 08/2013
1	Granuloma 04/2013
1	Pulmonary Sarcoidosis 04/2013
1	Dehydration (Water Stress) 09/2012
1	Reinfection 06/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2012
1	Chronic Pain 06/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 04/2013
4	AntibodiesIBA 01/2022 - 04/2016
4	Vascular Endothelial Growth Factor CIBA 01/2022 - 04/2013
3	InterferonsIBA 12/2021 - 08/2013
3	Capsid Proteins (Capsid Protein)IBA 10/2021 - 10/2007
3	ParaffinIBA 01/2018 - 04/2016
3	Vascular Endothelial Growth Factor DIBA 12/2016 - 04/2013
2	LipopolysaccharidesIBA 01/2022 - 12/2021
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022 - 12/2016
2	Isoaspartic Acid (Isoaspartate)IBA 03/2018 - 04/2016
2	Protein D-Aspartate-L-Isoaspartate Methyltransferase (Protein L Isoaspartate D Aspartate O Methyltransferase)IBA 03/2018 - 04/2016
2	Cyclophilin AIBA 01/2018 - 10/2009
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Interferon Type IIBA 12/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2021
1	Viral DNAIBA 12/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Dialysis SolutionsIBA 01/2020
1	Biological ProductsIBA 12/2019
1	AlginatesIBA 01/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	D-Aspartic Acid (D Aspartate)IBA 03/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 03/2018
1	ThapsigarginIBA 03/2018
1	TransferasesIBA 03/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Capsules (Microcapsules)IBA 11/2017
1	Antiviral Restriction FactorsIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 05/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2016
1	MethyltransferasesIBA 04/2016
1	Vascular Endothelial Growth FactorsIBA 01/2015
1	Interleukin-13IBA 09/2013
1	Immunoglobulin E (IgE)IBA 09/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2013
1	Imatinib Mesylate (Gleevec)FDA Link 08/2013
1	InterleukinsIBA 08/2013
1	Phenobarbital (Luminal)FDA Link 08/2013
1	Platelet-Derived Growth FactorIBA 08/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2013
1	Tyrosine (L-Tyrosine)FDA Link 08/2013
1	Interleukin-4 (Interleukin 4)IBA 08/2013
1	Interleukin-5 (Interleukin 5)IBA 08/2013
1	T-2 Toxin (T 2 Toxin)IBA 01/2013
1	IodidesIBA 09/2012

Therapy/Procedure

4	Peritoneal Dialysis 01/2021 - 11/2017
3	Therapeutics 01/2021 - 09/2004
1	Ileostomy 01/2020
1	Punctures 01/2019
1	Jejunostomy 11/2017
1	Jejunoileal Bypass 11/2017
1	Ambulatory Care (Outpatient Care) 05/2016
1	Adjuvant Chemotherapy 04/2016
1	Fluid Therapy (Oral Rehydration Therapy) 09/2012
1	Kidney Transplantation 06/2012
1	Nephrectomy 06/2012